ÂÜÀòÂÒÂ×

Dalit Hazan is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as a member of Cohort #6 at 8400 The Health Network since February 2023, Dalit has held various senior leadership roles at PolyPid Ltd. since April 2016, including Deputy Chief Executive Officer and EVP of Regulatory Affairs, Clinical & R&D. Prior experience includes key positions at Teva Pharmaceutical Industries Ltd., where Dalit led Global Regulatory Affairs Compliance and Administration and managed the Regulatory Affairs department for the Operation Division in Israel. Dalit's career began at Dexcel Pharma, overseeing the International Regulatory Affairs department. Dalit holds an Executive MBA from Bar-Ilan University, a Master of Science in Physiology and Pharmacology from Tel Aviv University, and a Bachelor's degree in Biology from Tel Aviv University.